Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD
Abstract Background The inflammatory biomarker soluble urokinase plasminogen activator receptor (suPAR) is elevated in severe acute and chronic medical conditions and has been associated with short-term mortality. The role of suPAR in predicting risk of death following an acute exacerbation of chron...
Main Authors: | Nina S. Godtfredsen, Ditte V. Jørgensen, Kristoffer Marsaa, Charlotte S. Ulrik, Ove Andersen, Jesper Eugen-Olsen, Line J. H. Rasmussen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-05-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12931-018-0803-2 |
Similar Items
-
COPD exacerbation: factors influencing hospitalization duration.
by: K. Yu. Gashynova
Published: (2015-03-01) -
Standardisation of Clinical Assessment, Management and Follow-Up of Acute Hospitalised Exacerbation of COPD: A Europe-Wide Consensus
by: Ramakrishnan S, et al.
Published: (2021-02-01) -
Patient and Health Care Provider Perspectives on Potential Preventability of Hospital Admission for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Qualitative Study
by: Leenders A, et al.
Published: (2022-12-01) -
Acute exacerbations of COPD
by: W MaxNee
Published: (2003-05-01) -
COPD patients prescribed inhaled corticosteroid in primary care: time for re-assessment based on exacerbation rate and blood eosinophils?
by: Osman Savran, et al.
Published: (2021-02-01)